Table 1. Design of SCI combination therapy study.
Combination Scaffolds | Heparin | ATIII peptide | NT-3/PDGF | NEP1–40 PLGA microspheres |
ChABC lipid microtubes |
Selected pMNs |
---|---|---|---|---|---|---|
GFs (n=5) | X | X | X | |||
pMNs+GFs (n=5) | X | X | X | X | ||
AIMS (n=6) | X | X | ||||
pMNs+AIMS (n=7) | X | X | X | |||
GFs+AIMS+pMNs (n=6) | X | X | X | X | X | X |